Showing 191-200 of 1743 results for "".
Treating Early Relapsing Multiple Sclerosis: Induction & Escalation Approaches
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/treating-early-relapsing-multiple-sclerosis-induction-escalation-approaches/31873/Evidence-based clinical trial results are needed to guide this difficult decision-making processDementia Insights: The World Turned Upside Down:
July 2023—A Remarkable Month in the World of Alzheimer Disease Diagnosis and Treatmenthttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-the-world-turned-upside-downbrjuly-2023-a-remarkable-month-in-the-world-of-alzheimer-disease-diagnosis-and-treatment/32075/A review of recent drug approvals, policy changes, and significant studies in the field.Neuropsychologic Approaches to Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/neuropsychologic-approaches-to-dementia/31799/Neuropsychologic test scores must be used in tandem with other data to elucidate the underlying etiology of dementia.The Unrecognized Value of Neurohospitalist Fellowships-Reframing Perspectives
https://practicalneurology.com/archives/2025-mar/the-unrecognized-value-of-neurohospitalist-fellowships-reframing-perspectives/35449/Neurohospitalist fellowships enhance clinical expertise and provide a foundation in leadership, research, and systems administration, empowering future neurologists to thrive in an evolving health care landscape while improving patient outcomes.Antisense Oligonucleotide Therapies
https://practicalneurology.com/diseases-diagnoses/movement-disorders/antisense-oligonucleotide-therapies/31573/Antisense oligonucleotides are a promising new therapeutic class being studied for the treatment of movement disorders.Epilepsy Essentials: Neuromodulation for Drug-Resistant Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-neuromodulation-for-drug-resistant-epilepsy/31805/Neuromodulation devices provide options for individuals with drug-resistant epilepsy not suited, or not responsive, to resective treatment.Management of Headache in Pregnant Women
https://practicalneurology.com/diseases-diagnoses/headache-pain/management-of-headache-in-pregnant-women/31998/Current recommendations for preventive and acute headache treatments, including off-label options, in pregnant women.Continuous Movement of the Toes
https://practicalneurology.com/diseases-diagnoses/movement-disorders/continuous-movement-of-the-toes/31107/In this case, we present a 26-year-old African American male with an 18-month history of constant involuntary alternating dorsiflexion-plantar flexion movements of his left toes, especially the big toe. With manual interference and conscious attention, he could eliminate the movement. He had dull pa- Vascular Clinichttps://practicalneurology.com/columns/practice-management/vascular-clinic/31131/The Crucial Role of Medical Directors in Stroke ProgramsIn the realm of stroke management, the selection of a medical director is pivotal to the success of a stroke program. Typically filled by a neurologist, this leadership position demands significant time and dedication, often exceeding initial e
- Editor's Messagehttps://practicalneurology.com/columns/practice-management/editors-message/31303/In the evolving landscape of medical specialization, the editorial from Practical Neurology emphasizes the critical need to bridge the gap between neurology and psychiatry. As medical advancements continue to proliferate, physicians face the challenge of staying abreast with the latest research, mak